Nanoparticle Technology Allows New Application of Antimicrobial Silver to Medical Devices

Article

PORTLAND, Ore. -- A scientific breakthrough in nanotechnology that has direct implications in the battle against hospital-acquired infections was presented last week at the Micro Nano Breakthrough Conference. Bruce Gibbins, PhD, founder and chief technology officer of Portland-based AcryMed, Inc., presented findings on AcryMeds new silver nanoparticle technology, SilvaGard. Through the discovery of how to create nanoparticles of silver in a solution that are easy to use and tenaciously adhere to surfaces, SilvaGard allows medical device manufacturers to apply antimicrobial silver to device surfaces in a uniform, non-hazardous and cost effective manner.  For the first time, antimicrobial products can be created that are chemically and dimensionally unchanged, thus retaining all of their intended properties. SilvaGard has already been licensed for its first medical device application and is currently in production.

This is an important step forward in the fight against a serious public health problem, hospital-acquired infections, stated Jack McMaken, president and CEO of AcryMed. There are 2 million hospital-acquired infections annually in this country, with 90,000 resulting in death. About half of these infections are associated with catheters and other percutaneous devices that provide a support surface for organisms to track into deeper tissue. A typical infection can cost as much as $47,000 per patient to treat. Our SilvaGard treatment provides a legitimate solution to many of these hospital related, life threatening infections by preventing the formation of biofilms on medical devices.  

SilvaGard is a new technology developed by AcryMed that is based on years of work with silver antimicrobial applications. AcryMeds SilvaSorb® wound dressings and SilvaSorb gel are recognized worldwide in the advanced wound-care industry. 

Source: AcryMed

Related Videos
Lila Price, CRCST, CER, CHL, the interim manager for HealthTrust Workforce Solutions; and Dannie O. Smith III, BSc, CSPDT, CRCST, CHL, CIS, CER, founder of Surgicaltrey, LLC, and a central processing educator for Valley Health System
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Related Content